MB

Matthew Buten

Chief Financial Officer at Biohaven Pharmaceuticals

New York, New York

Overview

Work Experience

  • Chief Financial Officer

    2021 - Current

  • Advisor

    2021 - 2022

  • Managing Director

    2013 - 2021

  • Board Member

    2014 - 2016

  • Portfolio Manager

    2007 - 2012

    Healthcare long/short portfolio

  • Co-Founder, Co-Portfolio Manager

    2005 - 2007

    Long-short healthcare hedge fund

  • Co-Founder and Partner

    2000 - 2005

    Co-founder and Sr. Equity analyst for $1.2 billion long/short healthcare hedge fund.

  • Managing Director, Partner

    1996 - 2000

    Investment Banker, Healthcare

  • Director

    1985 - 1996

    Investment Banking, SW Region - Energy, Industrials, Airlines

Relevant Websites